What's all the 'hype' about?
Cannabidiol, or CBD oil, is a new buzzword that you may be hearing. Its properties are suggested to treat a variety of ailments and illnesses, but what, exactly, is CBD?
CBD is a cannabis compound (cannabinoid) that has significant medical benefits, but does not make people feel “high” and can actually counteract the psychoactivity of THC. The fact that Bella Rose CBD oil is THC-Free & non-psychoactive makes it an appealing option for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, neurodegenerative diseases, spasms, and other conditions without disconcerting feelings of lethargy or dysphoria & little to no side effects.
CBD is gaining MAJOR traction in the medical community....
Scientific and clinical research—much of it sponsored by the US government or studied by Governments abroad—underscores CBD’s potential as a treatment for a wide range of conditions, including arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, depression, antibiotic-resistant infections, epilepsy, and other neurological disorders. CBD has demonstrable neuroprotective and neurogenic effects, and its anti-cancer properties are currently being investigated at several academic research centers in the United States and elsewhere. Further evidence suggests that CBD is safe even at high doses.
MORE AND MORE COUNTRIES ARE ALLOWING THE MEDICINAL USE OF CANNABINOIDS.
This growing acceptance is driven by the potential of cannabinoids, particularly CBD, to meet crucial, unmet needs for non-toxic, healthful and effective alternatives to existing therapies, to better treat serious health conditions and to otherwise safely and responsibly promote well-being.
Diabetes and chronic pain are public health nightmares for which CBD may play especially important therapeutic roles. Our group owns pertinent patents in this regard, and these conditions comprise enormous markets. Diabetes sufferers worldwide now number 371 million anticipated by 2030. Conservatively, about $36 billion was spent globally in 2014 for diabetes medicine alone. Worldwide, 349 million people (more than 100 million in the US) suffer from chronic pain, and annual costs for pain medicine exceeds $50 billion ($20 billion in the US).